Oil Demand Destruction Is Here Amid Ukraine War, JPMorgan Says

image

(Bloomberg) — Commodities markets have a well-worn saying that “the cure for high prices is high prices.” According to JPMorgan Chase & Co., the process may just be starting to happen in oil.

Consumers are feeling the pinch as oil has jumped to more than $100 a barrel following Russia’s invasion of Ukraine. But the actual war in Ukraine, the financial sanctions targeting Russia and the spread of the omicron variant in China have all had even more of a direct impact on oil demand than those elevated prices, according to the bank.

“High prices are clearly not the only demand-destructive force in the world at the moment,” JPMorgan analysts including Natasha Kaneva wrote in a note Thursday.

JPMorgan cut its second-quarter demand forecast by 1.1 million barrels a day, and reduced the outlook for both of the two remaining quarters by about 500,000 barrels. The “revisions are heavily concentrated in Europe, which remains the epicenter of the geopolitical shock,” the analysts said.

After a month of record high fuel prices, data suggest consumers are starting to react, they said. Brent crude has surged since Russia invaded Ukraine, trading at over $139 a barrel, the highest price since 2008.

READ: Gasoline Demand in U.S. Starts to Show Cracks at Unlikely Time

JPMorgan said its baseline assumptions include the view that the oil market’s “extreme aversion” to Russian crude will subside. It sees “stranded” Russian oil falling to 2 million barrels per day in April and a perpetual 1 million thereafter, compared with as much as 3.5 million in March. The bank said that will lead to an average price of $114 a barrel for Brent in the second quarter and $101 for the rest of the year.

©2022 Bloomberg L.P.

 
Trending Ideas

Featured Stocks On The Move

Daily Rundown

Top 3 Stocks in Leading Sectors
  • 3 Software Stocks To Buy Now

    International Business Machines Corporation (IBM) International Business Machines Corporation (IBM) is a global leader in cloud computing, AI, and enterprise software. The company provides IT infrastructure, cybersecurity, and quantum computing... Read More

  • 3 Food Stocks To Buy Now

    The Campbell’s Company (CPB) The Campbell’s Company is a leading producer of packaged foods and beverages, known for its soups, sauces, and snacks. With brands like Campbell’s, Pepperidge Farm, and... Read More

  • 3 Utility Stocks To Buy Now

    IDACORP, Inc. (IDA) IDACORP, Inc. is a utility holding company that provides electricity through its subsidiary, Idaho Power. The company focuses on renewable energy initiatives, grid modernization, and sustainable power... Read More

  • 3 Biotechnology Stocks To Buy Now

    Xeris Biopharma Holdings, Inc. (XERS) Xeris Biopharma Holdings, Inc. is a specialty pharmaceutical company focused on developing and commercializing innovative injectable drug formulations. Its proprietary technology enhances drug stability and... Read More

  • 3 Consumer Service Stocks To Buy Now

    TripAdvisor, Inc. (TRIP) TripAdvisor, Inc. operates the world’s largest travel guidance platform, offering user-generated reviews, price comparisons, and booking services for hotels, attractions, and restaurants worldwide. Chart Wynn Resorts, Limited... Read More

  • 3 Software Stocks To Buy Now

    Udemy, Inc. (UDMY) Udemy, Inc. is an online learning platform offering a vast catalog of courses across various fields. The company connects learners with expert instructors, providing affordable and accessible... Read More

  • 3 Energy Stocks To Buy Now

    Ranger Energy Services, Inc. (RNGR) Ranger Energy Services, Inc. provides well services and support for oil and gas production. The company specializes in high-spec rig solutions, completion services, and workover... Read More

  • 3 Pharmaceutical Stocks To Buy Now

    ACADIA Pharmaceuticals Inc. (ACAD) ACADIA Pharmaceuticals Inc. is a biopharmaceutical company focused on developing therapies for central nervous system disorders. The company’s lead product, NUPLAZID, is used to treat Parkinson’s... Read More